Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Urine test could reveal how HPV vaccine fights the virus

NCT ID NCT07407569

First seen Feb 19, 2026 · Last updated May 25, 2026 · Updated 14 times

Summary

This study looks at how the Gardasil-9 HPV vaccine changes the virus's ability to infect cells in women who already have HPV16. About 50 women aged 18-45 will get two vaccine doses and provide urine and blood samples over 24 months. The goal is to see if the vaccine reduces the virus's infectivity and to track immune responses in urine.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMA VIRUS INFECTION TYPE 16 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Antwerp University Hospital

    RECRUITING

    Antwerp, Wilrijk, 2650, Belgium

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • University Hospital Ghent

    RECRUITING

    Ghent, 9000, Belgium

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University Hospital Leuven

    RECRUITING

    Leuven, 3000, Belgium

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.